Medtronic Ardian Luxembourg S.a.r.l.

Foundry Therapeutics, Inc.

Medtronic Ireland Manufacturing Unlimited Company

Apreo Health, Inc.

Karun D Naga

Mark Gelfand

Denise Marie Zarins

Roman Turovskiy

Hanson S Gifford, Iii

Mark S Leung

Brian Kelly

Naomi Buckley

Danny Donovan

Luke Hughes

Benjamin J Clark

John Kelly

Stephen Nash

Fiachra Sweeney

Grace Kelly

Eric Ryba

Lana Woolley

Michael Cummins

Barry Mullins

Vincenzo Tilotta

Honglei Wang

Koon Kiat Teu

Jingnan Luo

Daniel Boon Lim Seet

Jackie Joe Hancock

Patrick H Ruane

Gary Kelly

Arye Rosen

Gwenda McMullin

Stephen W Boyd

Michael Turovskiy

Martin L Mayse

Michael Steven Feldstein

Gwenda Francis

Michael J Hendricksen

Steven W Kim

Douglas S Sutton

Stephen A Boyd

Patrick Peichen Wu

Wei Li Lee

Gary P Kelly

Seamus Ledwith

Nifer Beth Goldman

Jagannath Padmanabhan

Michael Feldstein

John H Morriss

Mark E Deem

Francesco Piccagli

Micheal Moriarty

Ronan Wood

Lana Wooley

Nassireddin Mokarram-Dorri

Vicenzo Tilotta

Benjamin C Clark

Stephen Naash

Gwenda Mcmullin

Benjamni J Clark

An implant in accordance with an embodiment of the present technology includes proximal and distal end portions spaced apart from one another along a longitudinal axis and configured to be deployed at first and second airways, respectively, of a bronchial tree, the second airway being of a greater generation than the first airway. The implant includes a wire extending along a wire path within a tubular region coaxially aligned with the longitudinal axis. The wire includes first and second legs alternatingly disposed along the wire path and extending distally and proximally, respectively, in a circumferential direction about the longitudinal axis. The implant is configured to transition from a low-profile delivery state to an expanded deployed state at a treatment location and to allow mucociliary clearance from immediately distal to the implant to immediately proximal to the implant while the in deployed at the treatment location.

Endobronchial implants and related technology

The present technology relates to depot assemblies for the controlled, sustained release of a therapeutic agent. The assembly can include a depot having a therapeutic region comprising a therapeutic agent, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.

Implantable polymer depots for the controlled release of therapeutic agents

Microwave catheter apparatuses, systems, and methods for achieving renal neuromodulation by intravascular access are disclosed herein. One aspect of the present application, for example, is directed to apparatuses, systems, and methods that incorporate a catheter treatment device comprising an elongated shaft. The elongated shaft is sized and configured to deliver a microwave transmission element to a renal artery via an intravascular path. Renal neuromodulation may be achieved via dielectric heating in the presence of microwave irradiation that modulates neural fibers that contribute to renal function or alters vascular structures that feed or perfuse the neural fibers.

Catheter apparatuses, systems, and methods for neuromodulation

The devices, systems, and methods disclosed herein may be directed to a delivery system including a therapeutic member configured for endoluminal placement via the delivery system into the esophagus of the patient, wherein the therapeutic member comprises a treatment portion comprising a film for controlled release of a chemotherapeutic agent. The film may comprise a control region, a therapeutic region, and a substantially impermeable base region. The film is configured to release the chemotherapeutic agent in a direction away from the substantially impermeable base region. The delivery system is configured to enable a treatment provider to position the treatment portion of the therapeutic member proximate to a treatment site associated with the esophagus of the patient, and the therapeutic member is configured to administer a therapeutically effective dose to the treatment site for a sustained period following endoluminal placement of the therapeutic member.

Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents

The present technology relates to depots for the treatment of postoperative pain via sustained, controlled release of a therapeutic agent. In some embodiments, the depot may comprise a therapeutic region comprising an analgesic, and a control region comprising a bioresorbable polymer and a releasing agent mixed with the polymer. The releasing agent may be configured to dissolve when the depot is placed in vivo to form diffusion openings in the control region. The depot may be configured to be implanted at a treatment site in vivo and, while implanted, release the therapeutic agent at the treatment site for no less than 3 days.

Implantable depots for the controlled release of therapeutic agents

Neuromodulation cryotherapeutic devices and associated systems and methods are disclosed herein. A cryotherapeutic device configured in accordance with a particular embodiment of the present technology can include an elongated shaft having distal portion and a supply lumen along at least a portion of the shaft. The shaft can be configured to locate the distal portion intravascularly at a treatment site proximate a renal artery or renal ostium. The supply lumen can be configured to receive a liquid refrigerant. The cryotherapeutic device can further include a cooling assembly at the distal portion of the shaft. The cooling assembly can include an applicator in fluid communication with the supply lumen and configured to deliver cryotherapeutic cooling to nerves proximate the target site when the cooling assembly is in a deployed state.

Neuromodulation cryotherapeutic devices and associated systems and methods

Microwave catheter apparatuses, systems, and methods for renal neuromodulation

Growing community of inventors

Los Altos, CA, United States of America

Karun D Naga